Mandating a Novel Vaccine is a Novel Legal Issue

Mandating a Novel Vaccine is a Novel Legal Issue

The emergency use authorization (EUA) granted to vaccine manufacturers by the U.S. Food and Drug Administration (FDA) to allow experimental COVID-19 vaccines to be distributed to the U.S. population states that the product is “an investigational vaccine not licensed for any indication” and requires that all “promotional material relating to the COVID-19 Vaccine clearly and […]

Dentists, Optometrists, Podiatrists Can Now Administer COVID-19 Vaccines in the U.S.

Dentists, Optometrists, Podiatrists Can Now Administer COVID-19 Vaccines in the U.S.

The U.S. Department of Health and Human Services (HHS) has announced that the agency is amending an emergency declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to authorize additional medical professionals to administer experimental COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA).1 2 This announcement was made after President Biden […]

2005 PREP Act and 1986 Act Shield Vaccine Manufacturers from Liability

2005 PREP Act and 1986 Act Shield Vaccine Manufacturers from Liability

Story Highlights Most countries that have supply contracts with AstraZeneca have granted the drug company liability protection for their COVID-19 vaccine. In the U.S., vaccine manufacturers and administrators are shielded from liability under the PREP Act of 2005 for a vaccine or drug that is developed in response to a declared public health emergency, including […]